Zoetis Inc.
ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biologicaā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
12 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$124.64
Price-0.96%
-$1.20
1Y
Price
Market Cap
$54.926b
Large
Price/Earnings 3y Avg5y Avg
21x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+44.5%
EBITDA Margin+30.0%
Net Profit Margin+33.5%
Free Cash Flow Margin+44.5%
EBITDA Margin+30.0%
Net Profit Margin+33.5%
Free Cash Flow MarginRevenue
$9.397b
+1.5%
1y CAGR+5.2%
3y CAGR+4.9%
5y CAGREarnings
$2.651b
+6.6%
1y CAGR+7.9%
3y CAGR+6.8%
5y CAGREPS
$5.94
+8.6%
1y CAGR+9.8%
3y CAGR+8.6%
5y CAGRBook Value
$5.398b
$15.159b
Assets$9.761b
Liabilities$7.273b
DebtDebt to Assets
48.0%
1.8x
Debt to EBITDAFree Cash Flow
$2.240b
-2.5%
1y CAGR+20.5%
3y CAGR+9.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company